Related research found that overexpression of the SLC2A protein isoform is associated with poor clinical outcomes in COAD patients (53), and that SLC2A3 may participate in the immune response of COAD through PD-L1 (54). The gene discussed is CD274; the disease is colon adenocarcinoma.